Concepedia

Janvi Sah

JS

9

Publications

270

Citations

9

H-Index

2019

Active since

Affiliations

STATinMED (United States)(Current)

Pfizer (United States)

King's College London

Guy's and St Thomas' NHS Foundation Trust

Bristol-Myers Squibb (United States)

Janvi Sah is an author at STATinMED (United States) specializing in medicine, atherosclerosis, and stroke.

ORCID

Top concepts

Publications per year

2019–2022

9

Publications

9

Treatment patterns and survival in metastatic castration‐sensitive prostate cancer in the US Veterans Health Administration

Stephen J. Freedland, Rickard Sandin, Janvi Sah et al. · Cancer Medicine · 2021 · 55 citations · Full text

Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States

Furaha Kariburyo, Lin Xie, Janvi Sah et al. · Journal of Medical Economics · 2019 · 41 citations

Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease

Alexander T. Cohen, Janvi Sah, Amol D. Dhamane et al. · Thrombosis and Haemostasis · 2021 · 40 citations · Full text

, , +18

Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A U.S. Claims Data Analysis

Alexander T. Cohen, Allison Keshishian, Theodore Lee et al. · Thrombosis and Haemostasis · 2020 · 38 citations · Full text

Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity

Alexander T. Cohen, Janvi Sah, Theodore Lee et al. · Journal of Clinical Medicine · 2021 · 36 citations · Full text

Rows per page

1–5 of 9